Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
With slow sales, BioMarin weighs Roctavian divestiture
BioMarin has now added a divestiture to the list of potential paths for the struggling hemophilia A gene therapy Roctavian.
Zoey Becker
Apr 29, 2024 11:51am
X4 snags FDA approval for its first drug Xolremdi
Apr 29, 2024 11:28am
Sponsored
ADVI Experts Discuss the Future of the Inflation Reduction Act
Apr 29, 2024 8:00am
Novo Nordisk's weekly insulin will get FDA adcomm review
Apr 29, 2024 11:08am
Sponsored
Collaborative partnerships key to clearing the path for new biopharma products
Apr 29, 2024 8:00am
AZ, Daiichi tout Enhertu win in earlier, broader HER2-low cancer
Apr 29, 2024 10:38am